Sarepta Therapeutics Inc
Research Sarepta Therapeutics Inc (SRPT) on Bullrun: market cap USD 2.00B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSRPT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 2.00B
- Financial periodQ2 2026
- RevenueUSD 401.25M
- Net income-USD 4.89M
- Free cash flowUSD 196.52M
- Gross margin62.8%
Valuation Snapshot
latest market cap is USD 2.00B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.86B | -USD 713.41M | -USD 307.45M | 98.6% | -7.13 | USD 801.28M | USD 828.97M | USD 1.14B |
| FY2024 | USD 1.79B | USD 235.24M | -USD 342.74M | 88.5% | 2.34 | USD 1.10B | USD 1.14B | USD 1.53B |
| FY2023 | USD 1.14B | -USD 535.98M | -USD 577.10M | n/a | -5.8 | USD 428.43M | USD 1.34B | USD 859.34M |
| FY2022 | USD 843.77M | -USD 703.49M | -USD 356.17M | n/a | -8.03 | USD 966.78M | USD 1.54B | USD 384.95M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.00B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.26B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 11.78B | 51.1 | n/a | n/a |
| 2023 | 2023-12-29 | USD 9.02B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 11.37B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 7.85B | n/a | n/a | n/a |
About Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sarepta Therapeutics Inc's market cap?
Sarepta Therapeutics Inc's market capitalization is USD 2.00B.
What does Sarepta Therapeutics Inc do?
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.